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Abstract.  Exogenous plasma and endogenous cellular 
fibronectins on the surface of cultured fibroblasts and 
in extraceilular matrix fibrils were colocalized by 
fluorescent and high voltage immunoelectron micros- 
copy. Fibroblast cultures grown in the presence or ab- 
sence of cycloheximide were incubated with exogenous 
plasma  fibronectin labeled with fluorescein isothi- 
ocyanate. A  monoclonal antibody specific for the 
EIIIA sequence of cellular fibronectin was used to de- 
tect cellular fibronectin.  A  rabbit antifluorescein anti- 
body identified fluoresceinated plasma fibronectin. In 
cultures incubated in the presence of cycloheximide, 
plasma fibronectin was  bound to the cell surface and 
was assembled into extracellular fibrils.  In cultures 
grown in the absence of cycloheximide, plasma and 
cellular fibronectins were observed in the same matrix 
fibrils and  in the same locations on the cell surface. 
There was  not, however, random admixture of the two 
proteins. 
F 
IBRON ECTIN is a multifunctional glycoprotein that can 
be found in a fibrillar network in the extracellular ma- 
trix of connective tissues, basement membranes and 
cultured cells. There are at least 20 different forms of fibro- 
nectin that can be generated by alternative mRNA splicing 
of nascent mRNA (Schwarzbauer et al.,  1983,  1987a; Korn- 
blihtt et al.,  1984,  1985). Plasma fibronectin (pFN)  ~  differs 
from cellular fibronectin (cFN) in that it is  missing com- 
pletely two type III sequences (EDIIIA and EDIIIB) found 
in a portion of cFN subunits (Gutman and Kornblihtt, 1987; 
Schwarzbauer et al.,  1987a;  Zardi et al.,  1987).  Both pFN 
and cFN can be found in tissues and in extracellular matrix 
fibrils of fibroblasts cultured in serum (Hayman and Ruos- 
lahti,  1979;  Oh et al.,  1981). 
The incorporation of fibronectin into fibrils occurs prin- 
cipally at the cell surface (McKeown-Longo and  Mosher, 
1983) and requires the amino terminal portion of the mole- 
cule (McKeown-Longo and Mosher, 1985; McDonald et al., 
1987;  Schwarzbauer et al.,  1987b; Quade and McDonald, 
1988) and the cell adhesion domain (McDonald et al., 1987; 
Roman et al.,  1989). Both labeled pFN and cFN bind to the 
cell layer in two fractions, a deoxycholate-soluble fraction 
(cell surface fraction) and a deoxycholate-insoluble (extra- 
cellular matrix) fraction containing disulfide bonded fibro- 
nectin (McKeown-Longo and Mosher,  1983,  1984,  1985; 
Allio and McKeown-Longo, 1988). Pulse chase experiments 
indicate that fibronectin binds initially in the deoxycholate 
soluble fraction and is  transferred to the deoxycholate in- 
soluble fraction (McKeown-Longo and Mosher, 1983; Barry 
and Mosher,  1989). Binding and transfer can be downreg- 
1. Abbreviations used in this paper: cFN, cellular fibronectin; pFN, plasma 
fibronectin. 
ulated  with  cholera  toxin  (Allen-Hotfraann and  Mosher, 
1987) and upregulated with transforming growth tactor-beta 
(Allen-Hoffmann et al.,  1988)  or,  in HTI080 tumor cells, 
with dexamethasone (McKeown-Longo and Etzler,  1987). 
Immunoelectron microscopy studies indicate that the amino- 
terminal fragment of fibronectin binds to the cell surface of 
fibroblasts like the intact molecule, but does not colocalize 
with fragments of fibronectin containing the cell adhesion 
sites  (Peters and Mosher,  1987). Assembly of fibronectin 
fibrils therefore appears  to occur at  sites that  are distinct 
from or more complex than the  cell attachment receptor 
(Pierschbacher et al.,  1983; Pytela et al.,  1985; Ruoslahti 
and  Pierschbacher,  1987).  Soluble  fibronectin,  however, 
seems to interact with itself during formation of the fibronec- 
tin fibrils and can bind directly to matrix (Chernousov et al., 
1985;  Barry and Mosher,  1989). 
In this paper, we examined the binding and incorporation 
of  exogenous pFN and endogenous cFN in human skin fibro- 
blast cultures using fluorescent and immunoelectnan micros- 
copy. In the fluorescent microscopy studies, fibroblast ~|- 
tures were incubated with pFN labeled with FITC and then 
labeled with a monoclonal antibody specific for the EIIIA se- 
quence found in  cFN (Borsi et al.,  1987).  The antibody 
specific for cFN was localized using a rhodamine-conjugated 
goat anti-mouse IgG  Electron microscopy studies used a 
goat anti-rabbit lgG bound to  18-rim gold beads to detect 
rabbit antifluorescein antibodies reacting with FITC-pFN. A 
goat anti-mouse IgG coupled to 5-nm gold beads localized 
the monoclonal antibody specific for EIIIA in the electron 
microscopy studies.  These studies  show that exogenously 
added pFN binds to regions of the cell surface where cFN 
is also localized, but does not need to bind to cFN to enter 
the matrix. In addition, these studies show that in a fibronec- 
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ized in discrete patches along the fibril. 
Materials and Methods 
Cell Culture and Labeling Conditions 
Neonatal  human  foreskin  fibroblasts were  either  grown in  Ham's  F-12 
medium or Ham's F-12 and DME (1:1 ratio) supplemented with 10% FBS. 
Fibroblasts used in immunofluorescent studies were plated at a density 
of 3  x  105 cells onto glass coverslips in 35-mm dishes and grown for ei- 
ther 18 or 42 h at 37°C. Cycloheximide (25 ~g/rnl) was added to some of 
the cultures after 1 h. FITC-pFN (20 ~g/ml or 250 t~g/ml) was appiied to 
some cultures 2 h after plating. In other experiments, fibroblasts were grown 
for 18 or 42 h, then washed and treated with cycloheximide (25/xg/ml) for 
1 h. FITC-pFN was added to the cycloheximide-containing medium, and 
the cells were incubated for an additional 4 h. 
For immunoelectron microscopy studies, fibroblasts were seeded onto 
formvar-coated gold  grids  on glass  coverslips (Wolosewick and  Porter, 
1976) precoated with 160-180-kD cell attachment fragments of fibronectin 
(Williams et al., 1983; McKeown-Longo and Mosher,  1985). Fibroblasts 
were allowed to attach for 3 h before the fibmblasts were treated with 25 
/~g/ml cycloheximide for 18 h at 37°C. Some of the fibroblasts were then 
incubated with 20/zg/ml FITC-pFN for 3 h at 37°C. 
Preparation of  FITC-pFN and Colloidal Gold 
Antibody Complexes 
Plasma fibronectin was purified as described by Mosher and Johnson (1983). 
FITC-pFN  was prepared  using the procedure  of McKeown-Longo and 
Mosher (1983). Spectroscopy measurements at 280 and 495-nm indicated 
that the labeled protein contained '~3 FITC/subunit of fibronectin. 
Colloidal gold beads 18 nm in diameter (Au18) were prepared by reduc- 
ing gold chloride with trisodium citrate as described by Geoghegan and 
Ackerman (1977). Colloidal gold beads 5 nm in diameter (Aus) were pre- 
pared by reducing gold chloride with white phosphorus as described by 
DeMay 0983). 
Polyclonal antibodies to rabbit IgG and mouse IgG (Jackson Laboratory, 
Bar Harbor, ME) were coupled to Auls and Au5 beads, respectively, at pH 
9.0 using the procedure described by DeMay (1983). The minimal concen- 
tration of IgG necessary to stabilize l ml of the gold sol was determined 
using an absorption isotherm (Horisberger and Rosset,  1977). Unbound 
areas on the gold beads were blocked with  1% BSA, pH 9.0. 
Immunofluorescent Microscopy 
Fibroblasts were washed three times with 10 mM sodium phosphate (pH 
7.4) containing 150 mM sodium chloride and fixed for 30 min with 3.5% 
paraformaldehyde in 0.i  M sodium phosphate (pH 7.4). Fixed cells were 
labeled for 30 min with either a monoclonal antibody (IST-9) to the EIIIA 
domain of cFN or a monoclonal antibody (IST-7) to an adjacent region of 
fibronectin (Borsi et al., 1987). Ascites containing the antibodies was used 
at a dilution of 1:1,000 in 1% BSA in PBS. Cells were washed three times 
and then labeled with rhodamine-conjugated goat anti-mouse IgG in 1% 
ovalbumin in PBS for 45 rain. 
lmmunoelectron High Voltage  Electron Microscopy 
Fibroblasts were washed three  times with Hanks balanced salt solution 
(HBSS), prefixed with 0.1% glutaraldehyde, 0.1  M Hepes,  pH  7.0, and 
treated with sodium borohydride (0.5 mg/ml), 0.1 M Hepes, pH 7.0, for 10 
min.  Prefixed fibroblasts were labeled with rabbit antifluorescein serum 
(1:100 dilution), and mouse IST-9 ascites (1:100 dilution). The labeling was 
for 1 h at 23°C in 20 mM Tris-HC1, pH 8.2, containing 150 mM sodium 
chloride, 20 mM sodium azide and 1% BSA. Cells were washed three times 
with the same buffer and then incubated for 1 h at room temperature with 
anti-rabbit IgG and anti-mouse IgG antibodies conjugated to Auls and Au5 
gold beads, respectively, in the 20 mM Tris-HC1 (pH 8.2),  150 mM NaC1 
buffer contains 20 mM sodium azide and  1% BSA. The fibroblasts were 
washed with 20 mM Tris-HC1 (pH 8.2), containing 150 mM sodium chlo- 
ride and 20 mM sodium azide and prepared for electron microscopy as de- 
scribed previously (Peters and Mosher,  1987). 
Figure 1. Deposition of FITC-pFN in the presence of a preexisting cFN matrix. Cells were grown for 42 h, incubated with cycloheximide 
(25 tzg/ml) for 1 h, and then incubated for 4 h with cycloheximide  and 250 #g/ml FITC-pFN. Cells were fixed, labeled with IST-9 antibody 
and then labeled with a rhodamine-conjugated goat anti-mouse antibody. (A) FITC-pFN is observed in short fibrils along the retracting 
edges of the cell (arrows). The exogenous FITC-pFN appears to fill in areas along fibrils where little cFN had been deposited (arrows). 
(B) Immunofluorescence of the fibroblast in A. cFN is observed in patches and fibrils (arrowheads). cFN is also observed in fibrillar net- 
works that colocalize with FITC-pFN (open arrowheads). (C) Phase micrograph of A and B.  Bar,  13.3 ,um. 
The Journal of Cell Biology, Volume Ill, 1990  250 Figure 2.  Deposition of endogenous FN in cells with a preexisting matrix of FITC-pFN.  Cells were allowed to settle for 1 h and then 
treated with cycloheximide (25 #g/ml).  After  1 h in cycloheximide, FITC-pFN (20 #g/ml) was added. The cells were incubated for 18 h, 
washed free of cycloheximide and FITC-pFN, placed in fresh medium,  and incubated for an additional 3 h at 37°C to allow synthesis 
and deposition of cFN.  Cells were fixed and labeled with IST-9 to cFN as described  in Fig.  1. (A) FITC-pFN is observed in a punctate 
pattern (arrowheads) and in short fibrils on the cell surface (arrows). (B) Immunofluorescence of the fibroblast in A. Areas where there 
is no colocalization  between FITC-pFN  and cFN can be observed (arrows). (C) Phase micrograph of A and B. Bar, 13.3 #m. 
Morphometric  Analysis 
Micrographs of extracellular matrix fibrils were randomly chosen from 25 
different areas for each of the three experimental conditions analyzed.  The 
distribution of 5- and 18-nm gold beads along the length of fibrils (2.0/~m) 
was determined by counting the number of gold beads found in consecutive 
60-nm segments along the fibril.  The length of each region along the fibril 
containing either cFN or pFN was determined using an IBM-XT computer 
and the Morphometer program (Woods Hole Educational Associates, Woods 
Hole, MA). The Sigmaplot program (Jandel Scientific, Corte Madera, CA) 
and Surfer Program (Golden Software, Golden, CO) were used to further 
analyze and graph the data. 
Results 
Double  fluorescent microscopic studies  of fibroblasts cul- 
tured for 18 or 42 h and then treated with cycloheximide and 
FITC-pFN showed  that  pFN  does  not  necessarily bind to 
cFN on the cell surface (Fig.  1). The lack of colocalization 
was more marked in cultures  incubated with 250/~g/ml of 
FITC-pFN than with 20/~g/ml FITC-pFN. FITC-pFN was 
observed bound to the retracting edges of fibroblast surface 
along regions of the cell where very little cFN had previously 
been laid down (arrows). FITC-pFN was also observed bound 
to regions of the cell where cFN had previously been depos- 
ited (open  arrows).  Regions where only cFN existed were 
also observed (small arrowheads). 
The converse experiment was done in which fibroblast cul- 
tures were grown for 18 h in cycloheximide in the presence 
of FITC-pFN followed by incubation in the absence of exoge- 
nous FITC-pFN and cycloheximide (Fig. 2, A-C).  I11 these 
cultures,  FITC-pFN was found predominantly in linear ar- 
rangements.  The  newly  synthesized  cFN  did  not  always 
colocalize with the FITC-pFN and appeared on the cell sur- 
face in arrays or patches (arrow). 
A  number of controls were done. If cells were incubated 
with FITC-pFN in the absence of cycloheximide, FITC-pFN 
and  cFN  colocalized  at  the  fluorescent  microscopic  level 
with the exception of  patches of cFN that were observed be- 
tween the cells and coverslip. Under experimental conditions 
in  which  FITC-pFN did  not colocalize with IST-9,  FITC- 
pFN did coiocalize with IST-7, a  monoclonal antibody that 
does not distinguish between cFN and pFN. 
Fibroblasts incubated with or without FITC-pFN (20/~g/ 
ml) in the presence or absence of cycloheximide were pre- 
pared  by  similar protocols and  examined  by high  voltage 
electron microscopy. 
Fig.  3 A shows a fibroblast that had been grown for 24 h 
in the absence of cycloheximide and FITC-pFN and then la- 
beled with IST-9 and anti-FITC. Cellular fibronectin (5-nm 
beads) is observed on the cell surface along stress fibers at 
the retracting end of the  fibroblast and in fibrils in the ex- 
tracellular space. Only an occasional 18-nm gold bead mark- 
ing FITC-pFN is observed (also see Fig. 6). Presumably, this 
represents nonspecific binding  of the  anti-rabbit IgG-gold 
conjugate. 
When FITC-pFN was added in the absence of cyclohexi- 
mide, both cFN and FITC-pFN were observed distributed 
together in linear arrangements along the lateral and retract- 
ing edges of the fibroblast surface (Fig. 3 B). However, there 
was not complete admixture of the two labels suggesting that 
the FITC-pFN was not binding to cFN on the cell surface 
(Fig.  3  C). 
When  fibroblasts were incubated with FITC-pFN in the 
presence of cycioheximide and then labeled with anti-FITC 
and IST-9, FITC-pFN was observed bound to the cell surface 
in linear arrangements along the lateral and retracting edges 
of the fibroblast (Fig. 4 A). The markers for cFN on the cell 
Pesciotta Peters et al. Co-assembly of Cellular and Plasma Fibronectin  251 Figure 3. Immunoelectron micrographs of fibroblasts grown in the presence and absence of FITC-pFN.  Cells were labeled for FITC-pFN 
(18-nm beads) and cFN (5-nm beads) as described in Material and Methods. (A) Whole mount of fibroblast grown for 24 h in the absence 
of FITC-pFN. Cellular fibronectin localizes with bundles of microfilaments along the retracting edge of the fibroblast. It can also be ob- 
served in extracellular matrix fibrils. Occasionally  18-nm  gold beads are present (arrows). Bar, 0.25 #m. (B) Whole mount of fibroblast 
grown for 24 h in the presence of FITC-pFN.  Both cFN (small arrows) and FITC-pFN (large arrows) is observed in linear arrangements 
above bundles of microfilaments along the lateral edge of the fibroblast. Bar, 0.26 t~m. (C) Higher magnification of cell treated as described 
in B. Although both cFN and FITC-pFN are observed in the same vicinity, there appear to be discrete localized concentrations of each. 
Bar, 0.20 #m. (D) lmmunoelectron micrograph of extracellular matrix from cultures incubated with FITC-pFN Both cFN (arrowheads) 
and FITC-pFN (arrows) are observed grouped into separate clusters along the same fibrils. The impression that the clusters were binding 
to the same fibrils was confirmed by examination of stereo pairs.  Bar, 0.25 #m. 
surface were reduced  markedly compared to cells not  in- 
cubated in cycloheximide. What little cFN was observed on 
the cell surface did not appear to coiocalize with FITC-pFN 
(Fig. 4 B).  Fibrils composed primarily of FITC-pFN were 
observed in the extracellular space (also see Fig.  6). 
To verify the specificities of the labeling patterns,  fibro- 
blasts that had never been incubated with FITC-pFN and had 
been cultured in the presence of cycloheximide were labeled 
with  anti-FITC  and  IST-9 antibodies.  These  cells did  not 
show any labeling (Fig. 4 C). Fibroblasts incubated without 
primary antibodies to FITC and cFN also showed no labeling 
(not shown). 
The pattern of cFN and FITC-pFN in fibrils that contain 
both fibronectins was distinctive (Fig. 3 D). FITC-pFN (ar- 
rows) and  cFN  (arrowheads)  were  grouped  into  discrete 
regions of the  fibrils  so that one  area contained  predomi- 
nantly labels for cFN and an adjacent region contained labels 
for FITC-pFN. Fig. 5 A shows the distribution of FITC-pFN 
and cFN in consecutive 60-nm segments of the fibril in Fig. 
5 B.  It is apparent that whenever FITC-pFN (open circles) 
is observed, cFN (closed circles) is usually not observed and 
vice versa. There are only three places (arrows) along the 
fibril  (2.0  /~m  in  length)  where  cFN  and  FITC-pFN  co- 
localize. 
Several  additional  quantitative  analyses  were  done  on 
fibrils containing both cFN and FITC-pFN, fibrils contain- 
ing mostly cFN,  and fibrils containing mostly FITC-pFN. 
Fig. 6, A-C, shows the average numbers of 5- and 18-nm gold 
beads found in consecutive 60-nm segments along the length 
of these three types of matrix fibrils. In fibrils grown in the 
absence of cycloheximide and FITC-pFN and therefore con- 
taining  mostly cFN (Fig.  6  A), only an occasional  18-nm 
gold bead (corresponding to FITC-pFN) was found.  Like- 
wise, in fibrils from cultures grown in the presence of cyclo- 
heximide and  FITC-pFN  and  therefore containing  mostly 
FITC-pFN, only an occasional 5-nm gold (corresponding to 
cFN)  was found (Fig.  6  B).  When the average number of 
5- and 18-nm beads were analyzed in fibrils containing both 
FITC-pFN and cFN,  both labels are found throughout the 
length of the fibrils. The average numbers of the two labels 
in the three types of fibronectin fibrils are plotted against one 
another in Fig.  7. The points are divided into three groups 
and do not overlap with one another. 
Individual  measurements  from  60-nm  segments  along 
fibrils containing both cFN and FITC-pFN were plotted on 
a contour plot (Fig.  8; compare to Fig. 7).  Few of the seg- 
ments contained both 5- and  18-nm gold beads. Instead, in- 
dividual segments contained mainly 5- or 18-nm gold beads, 
as was found in fibrils containing only cFN or FITC-pFN. 
Discussion 
The immunoelectron microscopy studies together with the 
fluorescence studies show that FITC-pFN is treated like cFN 
The Journal of Cell Biology, Volume 11 I, 1990  252 Figure  4.  Immunoelectron  micrographs  of fibroblasts grown in the presence of cycloheximide. Cells were labeled as described  for Fig. 
3. (A) Whole mount of fibroblast.  Cycloheximide (25 #g/ml) was added 3 h after seeding. Cells were grown at 37°C for an additional 
18 h. Afterwards, FITC-pFN (20 #g/ml) was added, and the cells were incubated for an additional 3 h. FITC-pFN (18-nm beads) is observed 
along the lateral edges of the fibroblast and in extracellular  matrix fibrils (arrows).  The FITC-pFN on the cell surface colocalizes along 
bundles of microfilaments. Bar, 0.41 #m. (B) Higher magnification of cell treated as described in A. Occasionally, cFN (arrows)  are ob- 
served on the cell surface or in matrix fibrils. Bar, 0.16 #m. (C) Whole mount of fibroblast cultured with cycloheximide and no FITC-pFN. 
Neither  18- or 5-nm beads are observed on the cell surface.  Bar, 0.41 /zm. 
by cultured fibroblasts. Both FITC-pFN and cFN were found 
bound to the cell surface along specific regions of the cell. 
These  regions  that  occur  primarily  along  the  lateral  and 
retracting  edges of the  fibroblast cell  surface  were  shown 
previously to represent sites involved in the fibrillogenesis 
of fibronectin-gold complexes (Peters and Mosher,  1987). 
Our results support recent evidence (McKeown-Longo and 
Etzler,  1987;  Allen-Hoffmann et al.,  1988)  that exogenous 
pFN can bind to the cell layer and become incorporated into 
the extracellular matrix of cells with blocked protein synthe- 
sis. This finding suggests that molecules on the cell surface 
involved in fibronectin binding and matrix assembly have a 
long half-life.  It also demonstrates  that  pFN-cFN  interac- 
tions are not needed for the binding of exogenous pFN to the 
cell  surface.  The immunoelectron microscopy studies  fur- 
ther show that FITC-pFN was assembled into an extensive 
matrix within 3 h in the cycloheximide-treated cultures. Thus, 
pFN seems to contain all the structures needed for fibril as- 
sembly. 
The deposition of pFN in the matrix of cultured fibroblasts 
has  been  shown  to  be  dependent  on  the  concentration  of 
pFN  used.  Half maximal  rates  of incorporation  (Km) are 
achieved at about 25  #g/ml (Allen-Hoffmann et al.,  1988; 
Barry and Mosher, 1988). The matrix itself contains binding 
sites for pFN which seem to be nonsaturable (Chernousov 
et al.,  1985; Peters and Mosher,  1987). By fluorescence mi- 
croscopy of 18- or 48-h cultures pretreated with cyclohexi- 
mide for 1 h and then incubated with FITC-pFN, the FITC- 
pFN  colocalized  with  preexisting  fibrillar  cFN  and  also 
appeared to form new fibrils not containing cFN. The new 
fibrils were detected more easily in cultures incubated with 
250 #g/ml FITC-pFN (the plasma concentration but 10-fold 
higher than the estimated K., of incorporation) than in cul- 
tures incubated with 20 #g/ml FITC-pFN. This may be be- 
cause the higher concentrations of FITC-pFN competed for 
or excluded the trace amounts of cFN secreted by cyclohexi- 
mide-treated cells (estimated by immunoassay of medium to 
be ,05 % of nontreated cells).  At the electron microscopic 
level, when cultures were treated with cycloheximide 3 h af- 
ter plating, little cFN was found in fibrils of cycloheximide- 
treated cultures. 
The deposition of bulk cFN in medium appears to follow 
the same rules as deposition of pFN (Allio and McKeown- 
Longo, 1988).  There appeared, however, to be regions of the 
ventral cell surface where cFN was deposited preferentially. 
We speculate that cFN may be vectoriaily secreted to regions 
of the cell surface able to assemble fibronectin or into re- 
stricted volumes in which cFN is preferentially assembled. 
Our most intriguing finding is that when FITC-pFN and 
cFN coassemble into fibrils, the fibrils have regions enriched 
in one of the two forms. This finding could be due to vectori- 
ally or temporally regulated secretion; e.g.,  pulses of cFN 
secretion into assembly sites. We favor, however, the expla- 
nation that the orientation of fibronectin in fibrils may im- 
pose certain structural requirements that encourage cFN to 
bind  preferentially  to  cFN  and  pFN  to  bind  to  pFN.  As 
shown in Fig. 9, subunits containing EIIIA and/or EIIIB may 
preferentially interact with one another leading to an area 
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Figure 5. Distribution of cFN and FITC-pFN in matrix fibrils. (A) 
Graphic representation  of FN fibril shown in B. Closed circles de- 
note cFN; open circles  denote FITC-pFN. Arrows denote areas 
where discrete  patches of cFN and FITC-pFN are not apparent. 
(B)  Immunoelectron micrograph  of fibronectin  fibril (2.0 #m in 
length). FITC-pFN (large gold beads) and cFN (small gold beads) 
are grouped in discrete patches along the fibril. Arrowheads denote 
areas where discrete patches are not apparent.  Bar, 0.16 #m. When 
data from 25 randomly chosen fibrils were analyzed, it was found 
that the patches of cFN and FITC-pFN varied in length from 9 to 
812 nm for cFN and 28 to 1,200 nm for FITC-pFN. The average 
lengths of these patches were 152 nm for cFN and 172 nm for FITC- 
pFN. There are regions where no label is observed. This is presum- 
ably due to the fact that the IST-9 antibody recognizes only cFN 
molecules that have EIIIA inserts. 
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Figure  6.  Average numbers of 5- and 18-nm gold beads observed along 60-nm segments of FN fibrils.  Cells grown in (A) the absence 
of cycloheximide and FITC-pFN; (B) the presence of cycloheximide and FITC-pFN; or (C) the absence of cycloheximide and the presence 
of FITC-pFN. Open circles represent FITC-pFN; closed circles represent cFN. The distribution of the labels in C indicates that each seg- 
ment has the potential  to contain cFN and FITC-pFN (see also Fig. 7). 
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Figure  7.  Plot of the average number of 5-nm gold beads (cFN) 
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FN fibrils. Open circles represent data from cells grown in the ab- 
sence of cycloheximide and  FITC-pFN;  closed circles  represent 
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Figure 8.  Contour plot showing the distribution of numbers of 18- 
nm (FITC-pFN) and 5-nm (cFN) beads in individual 60-nm seg- 
ments  among  fibrils containing both  cFN  and  FITC-pFN.  The 
majority of 60-nm segments were enriched in either cFN or FITC- 
pFN (compare to average values shown in Fig. 7, closed circles). 
Measurements from 25 randomly chosen fibrils were plotted, N  = 
876. The number 4 represents the frequency with which data points 
are observed along that contour line. 
that is enriched in cFN and poor in FITC-pFN. Conversely, 
FITC-pFN  may assemble  with  itself unless  it encounters 
a  heterodimeric cFN  consisting  of one subunit  with  the 
EIIIA/B sequences and a second subunit lacking the EIIIA/B 
sequences. Such preferential binding and assembly would in- 
sure that cells induced to secrete certain isoforms of fibro- 
nectin, as happens with growth factor stimulation (Baiza et 
al.,  1988)  or during embryogenesis (ffrench-Constant and 
Hynes,  1988) and wound healing (ffrench-Constant et al., 
1989), are able to populate their matrix with the secreted iso- 
forms despite the presence of other isoforms of fibronectin. 
The data presented in this manuscript do not enable us to 
predict  the  exact  interactions between  neighboring  fibro- 
nectin molecules. Fig.  9 assumes a simple head-to-tail in- 
teraction of subunits.  Further studies  need to be done to 
determine  the  three-dimensional  structure  of fibronectin- 
containing fibrils and the exact sites of polymerization. 
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